Research

국제전문학술지

• Maternal obesity induced metabolic disorders in offspring and myeloid reprogramming by epigenetic regulation, Frontiers in Endocrinology, , 14, - (2024 )
• Non‐Invasive Photoacoustic Cerebrovascular Monitoring of Early‐Stage Ischemic Strokes In Vivo, Advanced Science, , , - (2024 )
• Contrast Agent‐Free 3D Renal Ultrafast Doppler Imaging Reveals Vascular Dysfunction in Acute and Diabetic Kidney Diseases, Advanced Science, , 10, - (2023 )
• Macrophagerestricted overexpression of glutaredoxin 1 protects against atherosclerosis by preventing nutrient stressinduced macrophage dysfunction and reprogramming, Atherosclerosis, , 387, 117383- (2023 )
• Glutaredoxin 1 controls monocyte reprogramming during nutrient stress and protects mice against obesity and atherosclerosis in a sexspecific manner, Nature Communications, , 13, - (2022 )
• Ursolic Acid and Related Analogues Triterpenoids with Broad Health Benefits, Antioxidants, , 10, 1161- (2021 )
• Inhibition of myeloid HDAC2 upregulates glutaredoxin 1 expression improves protein thiol redox state and protects against highcalorie dietinduced monocyte dysfunction and atherosclerosis, Atherosclerosis, , 328, 23-32 (2021 )
• Dietary 23hydroxy ursolic acid protects against dietinduced weight gain and hyperglycemia by protecting monocytes and macrophages against nutrient stresstriggered reprogramming and dysfunction and preventing adipose tissue inflammation, Journal of Nutritional Biochemistry, , 86, 108483- (2020 )
• Sexual dimorphism in glutathione metabolism and glutathionedependent responses, Redox Biology, , 31, 101410- (2020 )
• Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages, Journal of Visualized Experiments, , , - (2019 )
• Dietary 23–hydroxy ursolic acid protects against atherosclerosis and obesity by preventing dyslipidemiainduced monocyte priming and dysfunction, Atherosclerosis, , 275, 333-341 (2018 )
• CRC113 gene expression signature for predicting prognosis in patients with colorectal cancer, Oncotarget, , 6, 31674-31692 (2015 )
• SelectivescpROCKscp2 inhibition in focal cerebral ischemia, Annals of Clinical and Translational Neurology, , 1, 2-14 (2014 )
• AMPactivated protein kinase implications on ischemic diseases, BMB Reports, , 45, 489-495 (2012 )
• Plasmodium vivax Comparison of the immune responses between oral and parenteral immunization of rPv54 in BALBc mice, Experimental Parasitology, , 126, 217-223 (2010 )
• Blocking effect of a monoclonal antibody against recombinant Pvs25 on sporozoite development in Anopheles sinensis, Clinical and Vaccine Immunology, , 17, 1183-1187 (2010 )
• Risk Factors for Failure of Initial Intravenous Immunoglobulin Treatment in Kawasaki Disease, Journal of Korean Medical Science, , 23, 718- (2008 )

학회발표

• Inflammatory Response Induced by UltrasoundActivated Mechanosensitive Channels in Macrophages , , 0, 0, - (2024)
• Noninvasive Photoacoustic Cerebrovascular Monitoring of Earlystage Ischemic Strokes In Vivo, , 0, 0, - (2024)
• Soluble Uric Acid Induced Trained Immunity in Monocytes Implications for Atherosclerosis , , 0, 0, - (2024)
• Abstract 1069 Novel Approaches Dissecting Human Thrombus Composition, Arteriosclerosis Thrombosis and Vascular Biology, 0, 0, - (2024)
• Monocyte Priming and Macrophage Reprogramming in Atherosclerosis and DietInduced Obesity, , 0, 0, - (2024)
• Photoacoustic Imaging for Detecting Stroke Lesion and ROS Signal in a Photothrombotic Stroke Model , , 0, 0, - (2023)
• Gestational Diabetes Induced Inflammatory Signature of Human Placenta, , 0, 0, - (2023)
• Monocyte Priming and Macrophage Reprogramming in Atherosclerosis and DietInduced Obesity You Become What You Eat The Beginning of Cardiometaolic Diseases, , 0, 0, - (2022)
• Macrophagerestricted Overexpression of Glutaredoxin 1 Protects Mice Against Atherosclerosis and Obesity by Suppressing Nutrient Stresstriggered Induction of NADPH Oxidase and NO Synthases in Macrophages, , 0, 0, - (2022)
• Glutaredoxin 1 Controls the Sexual Dimorphic Expression of NADPH Oxidases and Nitric Oxide Synthases in Macrophages in Mice, , 0, 0, - (2021)
• Glutaredoxin 1 Controls the Sexual Dimorphic Reprogramming of Monocytes by Nutrient Stress and Protects Mice Against Obesity and Atherosclerosis, , 0, 0, - (2021)
• The Role of Monocytic Glutaredoxin 1 in Atherogenesis, , 0, 0, - (2020)
• Microglia Activation State as a Novel Biomarker for Outcomes After Spontaneous Intracerebral Hemorrhage A Proof of Concept Study, , 0, 0, - (2020)
• Neuronal ROCK2 Plays an Important Role in Ischemic Stroke GSK3beta and Tau Signaling Pathways, , 0, 0, - (2020)
• MacrophageSpecific Overexpression of Glutaredoxin 1 Protects Mice against Atherosclerosis and Monocyte Dysfunction by Preventing HighCalorie DietInduced Metabolic Reprogramming of Blood Monocytes, , 0, 0, - (2020)
• MacrophageSpecific Overexpression of Glutaredoxin 1 Protects Mice Against Atherosclerosis and Monocyte Dysfunction by Preventing PKM2 Induction, , 0, 0, - (2019)
• Monocytic Glutaredoxin 1 Protects Mice Against Obesity and Atherosclerosis by Preventing Dietinduced Monocyte Reprogramming and Dysfunction, , 0, 0, - (2019)
• Dietary 23Hydroxy Ursolic Acid Protects Protects Against Atherosclerosis and Obesity by Preventing DyslipidemiaInduced Monocyte Priming and Dysfunction, , 0, 0, - (2019)
• Monocytic glutaredoxin 1 protects mice against atherosclerosis and obesity by preventing dietinduced monocyte reprogramming and dysfunction, , 0, 0, - (2019)
• PKM2 Sglutathionylation promotes the reprogramming of macrophage metabolism and activation states, , 0, 0, - (2018)
• Monocytic Glutaredoxin 1 Protects Mice Against Obesity Hyperglycemia and Atherosclerosis, , 0, 0, - (2018)
• 23Hydroxy Ursolic Acid Protects Monocytes from Metabolic Dysfunction, , 0, 0, - (2017)
• Neuroprotective effect of nattokinase mediated by inhibition of platelet aggregation and thrombosis in photothrombotic stroke, , 0, 0, - (2015)
• Plateletspecific mTOR deficiency is an important mediator of arterial thrombosis, , 0, 0, - (2013)
• Endothelial cell and smooth muscle cell specific TSC1 deficiency are important mediators of ischemic stroke, , 0, 0, - (2013)
• Platelet TSC1 is an important mediator of arterial thrombosis, , 0, 0, - (2012)
• The inhibition of WWP1 and activation of AMPKα2 are important mediators of ischemic stroke, , 0, 0, - (2012)
• The role of mammalian target of rapamycin in focal cerebral ischemia the link between TSC2 and mTOR signaling pathway, , 0, 0, - (2011)
• Metformin prevents focal cerebral ischemic injury via AMPKS6 pathway in mouse model, , 0, 0, - (2010)